Review article · 2025 · Open access
PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation
Pharmaceutics, 17(4), 501 · Published 9 April 2025 · DOI 10.3390/pharmaceutics17040501
In brief
“PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation” is a 2025 review article by Endry Wahyu Syahputra and 5 co-authors, published in Pharmaceutics. OpenAlex counts 91 citations as of 19 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.
- Citations
- 91
- Most cited in
- 2026 (69)
- Field-weighted impact
- 6.30
- References
- 116
- Authors
- 6
Abstract
Proteolysis targeting chimeras (PROTACs), heterobifunctional molecules that hijack the ubiquitin-proteasome system (UPS) to degrade specific proteins, hold great promise in treating diseases driven by traditionally "undruggable" targets. However, their large molecular weight, high hydrophobicity, and other physicochemical hurdles contribute to their limited bioavailability, suboptimal pharmacokinetics, and attenuated therapeutic efficacy. Consequently, diverse formulation innovations have been investigated to optimize PROTAC delivery. This review examines current challenges and advances in specialized drug delivery approaches designed to bolster PROTAC pharmacological performance. We first outline the fundamental limitations of PROTACs-their low aqueous solubility, poor cell permeability, rapid clearance, and concentration-dependent "hook effect". We then discuss how various enabling formulations address these issues, including polymeric micelles, emulsions, amorphous solid dispersions, lipid-based nanoparticles, liposomes, and exosomes. Collectively, these delivery technologies substantially improve the therapeutic outcomes of PROTACs in preclinical cancer models. Future applications may extend beyond oncology to address other complex diseases using newly emerging heterobifunctional molecules. By integrating advanced formulation science with innovative degrader design, the field stands poised to unlock the clinical potential of PROTACs for protein degradation therapies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Syahputra, E. W., Lee, H., Cho, H. J., Park, H. J., Park, K., & Hwang, D. (2025). PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics, 17(4), 501. https://doi.org/10.3390/pharmaceutics17040501
MLA 9
Syahputra, Endry Wahyu, et al. “PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation.” Pharmaceutics, vol. 17, no. 4, 2025, p. 501. https://doi.org/10.3390/pharmaceutics17040501.
Chicago
Syahputra, Endry Wahyu, Hyunji Lee, Hyuk Jun Cho, Hyun Jin Park, Kwang‐Su Park, and Duhyeong Hwang. 2025. “PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation.” Pharmaceutics 17 (4): 501. https://doi.org/10.3390/pharmaceutics17040501.
Harvard
Syahputra, E. W. et al. (2025) ‘PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation’, Pharmaceutics, 17(4), p. 501. doi:10.3390/pharmaceutics17040501.
IEEE
E. W. Syahputra, H. Lee, H. J. Cho, H. J. Park, K. Park, and D. Hwang, “PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation,” Pharmaceutics, vol. 17, no. 4, p. 501, 2025, doi: 10.3390/pharmaceutics17040501.
BibTeX
@article{syahputra2025protac,
title = {{PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation}},
author = {Syahputra, Endry Wahyu and Lee, Hyunji and Cho, Hyuk Jun and Park, Hyun Jin and Park, Kwang‐Su and Hwang, Duhyeong},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {4},
pages = {501},
doi = {10.3390/pharmaceutics17040501},
url = {https://doi.org/10.3390/pharmaceutics17040501}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- targeted protein degradation
- drug delivery
- drug formulation
- pharmacokinetics
- bioavailability
- hook effect
- polymeric micelles
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Syahputra, E. W., Lee, H., Cho, H. J., Park, H. J., Park, K., & Hwang, D. (2025). PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics, 17(4), 501. https://doi.org/10.3390/pharmaceutics17040501
How many times has this paper been cited?
91 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.
Who wrote this paper?
Endry Wahyu Syahputra, Hyunji Lee, Hyuk Jun Cho, Hyun Jin Park, Kwang‐Su Park, Duhyeong Hwang.
What is the DOI of this paper?
10.3390/pharmaceutics17040501, permanently at https://doi.org/10.3390/pharmaceutics17040501. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.